CDC has updated its blood lead reference value (BLRV) from 5 µg/dL to 3.5 µg/dL in response to the Lead Exposure Prevention and Advisory Committee (LEPAC) recommendation made on May 14, 2021.
Magellan Diagnostics and the FDA have issued a recall notice concerning the use of some LeadCare® Blood Lead Tests distributed between 10/27/20 - 8/19/21.
Welcome to the Louisiana Healthy Homes and Childhood Lead Poisoning Prevention Program (LHHCLPPP)
The Louisiana Healthy Homes and Childhood Lead Poisoning Prevention Program is a program of the Louisiana Department of Health, Office of Public Health, Bureau of Family Health. Our program’s goals are to:
- eliminate childhood lead poisoning in Louisiana
- ensure that all healthcare providers test children under the age of six for lead in their blood
- reduce or eliminate lead in the home by testing homes and properties for lead hazards
- coordinate care for children affected by lead poisoning
Healthcare and social service providers, caregivers and families, and contractors and property owners all play a role in keeping Louisiana's children safe from lead poisoning. Browse the options below to find out what you need to know about lead, and what steps you can take to prevent lead poisoning.
For Healthcare and Social Service Professionals
For Families and Caregivers
Lead Abatement Services and Contractors
Visit here to learn more about programs within the Bureau of Family Health serving CYSHCN.
Press Announcements and Safety Alerts
November 16, 2021: CDC Releases Blood Lead Tables, NHANES 2011-2018
The CDC published updated blood lead summary data as a standalone resource in advance of the next scheduled update to the National Exposure Report. The updated Blood Lead, NHANES 2011-2018 table is available on CDC’s National Exposure Report webpage.
November 8, 2021: LeadCare® Blood Lead Test Recall FAQs
Check out these frequently asked questions (FAQs) about the LeadCare Blooc Lead Test Recall.
October 28, 2021: Update to CDC’s Blood Lead Reference Value
The Centers for Disease Control and Prevention (CDC) is updating its blood lead reference value (BLRV) from 5 µg/dL to 3.5 µg/dL in response to the Lead Exposure Prevention and Advisory Committee (LEPAC) recommendation made on May 14, 2021.
The BLRV is based on the 97.5th percentile of the blood lead level (BLL) distribution among children 1-5 years old in the U.S. from the two most recent cycles of data (i.e., 2015-2018) from the National Health and Nutrition Examination Survey (NHANES). Thus, based on NHANES data, CDC accepted the LEPAC recommendation to update the BLRV to 3.5 μg/dL.
October 24-30, 2021: National Lead Poisoning Prevention Week
Each year, National Lead Poisoning Prevention Week (NLPPW) is a call to bring together individuals, organizations, industry, and state, tribal, and local governments to increase lead poisoning prevention awareness in an effort to reduce childhood exposure to lead. Click the link below to learn more and help us heighten awareness of lead poisoning, provide resources, and encourage preventive actions during NLPPW and beyond.
October 15, 2021: CDC Health Alert for LeadCare® Blood Lead Test Recall
Magellan Diagnostics, Inc. and the U.S. Food and Drug Administration (FDA) have issued a recall notice concerning the use of some LeadCare® Blood Lead Tests (certain LeadCare II, LeadCare Plus, and LeadCare Ultra test kit lots). These lots were distributed between October 27, 2020, and August 19, 2021. The use of these devices may cause serious injuries because they might underestimate blood lead levels. The FDA has identified this as a Class I recall, the most serious type of recall. The Centers for Disease Control &Prevention (CDC) has issued a Health Alert Network (HAN) Health Advisory to notify healthcare providers, state and local health departments, tribal, territorial and other partners and stakeholders about this recall notice and to recommend appropriate follow-up actions.
August 27, 2021: Potential LeadCare® Test Kit Shortage
The Centers for Disease Control and Prevention (CDC)-Childhood Lead Poisoning Prevention Program, has raised concerns about potential shortages of LeadCare® test kits following the recall on July 2, 2021. These kits are used to analyze capillary blood lead samples from patients, and the potential shortage may result in fewer children receiving blood lead tests.
If LeadCare® test kits are unavailable, the CDC strongly recommends that healthcare providers not delay required blood lead testing for children. Blood lead testing can be done with either a venous or capillary blood sample, and submitted to a laboratory for analysis with higher complexity methods. Additionally, the CDC recommends that all healthcare providers contact laboratories for recommended blood collection.
July 8, 2021: Official CDC Health Advisory Recall of LeadCare Lead Tests
Magellan Diagnostics, Inc. and the U.S. Food and Drug Administration (FDA) have issued a recall notice concerning the use of some LeadCare® Blood Lead Tests (certain LeadCare II, LeadCare Plus, and LeadCare Ultra test kit lots). These lots were distributed between October 27, 2020, and June 15, 2021. The use of these devices may cause serious injuries because they might underestimate blood lead levels. The FDA has identified this as a Class I recall, the most serious type of recall.
June 18, 2018: LHHCLPPP celebrates National Healthy Homes Month from HUD and recognizes June 18th-23rd 2018 as Healthy Homes Week in Louisiana
March 22, 2018: Update from The U.S. Food and Drug Administration (FDA) on findings from ongoing investigations into Magellan Diagnostics LeadCare Testing.
August 4, 2017: Warning from the FDA regarding high levels of lead in Balguti Kesaria Ayurvedic Medicine
May 17, 2017: Warning from the FDA regarding the potential for falsely-low blood lead test results from Magellelan LeadCare